Casp6 cleaves two proteins known to be involved in AD: the amyloid β precursor protein (APP) and Tau [27], [29], [30] and Casp6 activation in human primary neurons leads to increased levels of amyloid beta peptide (Aβ) [27], [31]. Here, MAPT is linked to Alzheimer disease.